Corundum Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Hold |
549
| – | – | 0.1% | 97 |
|
|
2025
Q1 | $273K | Hold |
549
| – | – | 0.13% | 88 |
|
|
2024
Q4 | $286K | Sell |
549
-148
| -21% | -$77K | 0.11% | 85 |
|
|
2024
Q3 | $431K | Hold |
697
| – | – | 0.2% | 75 |
|
|
2024
Q2 | $385K | Sell |
697
-22
| -3% | -$12.2K | 0.15% | 76 |
|
|
2024
Q1 | $418K | Sell |
719
-22
| -3% | -$12.8K | 0.2% | 73 |
|
|
2023
Q4 | $393K | Sell |
741
-30
| -4% | -$15.9K | 0.2% | 77 |
|
|
2023
Q3 | $390K | Sell |
771
-129
| -14% | -$65.3K | 0.22% | 74 |
|
|
2023
Q2 | $470K | Hold |
900
| – | – | 0.23% | 77 |
|
|
2023
Q1 | $519K | Sell |
900
-589
| -40% | -$339K | 0.25% | 74 |
|
|
2022
Q4 | $820K | Hold |
1,489
| – | – | 0.46% | 56 |
|
|
2022
Q3 | $755K | Buy |
1,489
+300
| +25% | +$152K | 0.48% | 51 |
|
|
2022
Q2 | $646K | Sell |
1,189
-25
| -2% | -$13.6K | 0.44% | 61 |
|
|
2022
Q1 | $717K | Buy |
1,214
+561
| +86% | +$331K | 0.67% | 58 |
|
|
2021
Q4 | $436K | Buy |
653
+118
| +22% | +$78.8K | 0.28% | 67 |
|
|
2021
Q3 | $306K | Sell |
535
-252
| -32% | -$144K | 0.23% | 77 |
|
|
2021
Q2 | $397K | Sell |
787
-68
| -8% | -$34.3K | 0.26% | 60 |
|
|
2021
Q1 | $390K | Buy |
855
+50
| +6% | +$22.8K | 0.3% | 50 |
|
|
2020
Q4 | $375K | Sell |
805
-23
| -3% | -$10.7K | 0.31% | 47 |
|
|
2020
Q3 | $366K | Buy |
828
+276
| +50% | +$122K | 0.35% | 40 |
|
|
2020
Q2 | $200K | Buy |
+552
| New | +$200K | 0.24% | 58 |
|